- GlobeNewswire•7 days ago
GERMANTOWN, Md., Sept. 21, 2016-- Neuralstem, Inc., a biopharmaceutical company focused on the development of central nervous system therapies based on its neural stem cell technology, announced that it ...
- Capital Cube•15 days ago
Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Neuralstem, Inc. Here are 5 ETF’s with the largest exposure to CUR-US. Comparing the performance and risk of Neuralstem, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
- GlobeNewswire•16 days agoNeuralstem Presented NSI-189 Preclinical Data in Type 1 and Type 2 Diabetes at the Annual Meeting of the Diabetic Neuropathy Study Group
GERMANTOWN, Md., Sept. 12, 2016-- Neuralstem, Inc., a biopharmaceutical company focused on the development of central nervous system therapies based on its neural stem cell proprietary technology, announced ...
Neuralstem, Inc. (CUR)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Bid||0.06 x 5000|
|Day's Range||0.32 - 0.32|
|52wk Range||0.24 - 0.35|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-1.46|
|Avg Vol (3m)||1,016,208|
|Dividend & Yield||N/A (N/A)|